Skip to main content
. 2008 Mar 1;3(2):505–521. doi: 10.2215/CJN.03670807

Table 1.

List of traditional (i.e., Framingham), novel, and uremia-related biochemical risk factors proven (or hypothesized) to predict cardiovascular disease or outcome in patients with chronic kidney disease

Biochemical Risk Markers
Traditional risk factors Age
 Male gender
 Hypertension
 Left ventricular hypertrophy
 Smoking
 Diabetes mellitus HbA1c [52], glucose [53]
 Dyslipidemia Cholesterol [28], Lp(a) [189]
Novel risk and/or uremia-related risk factors
 Inflammation IL-6 [37], IL-18 [38], S-albumin [39], WBC [40], fibrinogen [41], hyaluronan [42], MPO [43], CRP [44], PTX3 [45]
 Oxidative stress MPO [43], plasmalogens [127], oxLDL [125], AOPP [126]
 Endothelial dysfunction PTX3 [45], ADMA [79], tHcys [47], U-albumin [87], VCAM [97]
 Protein-energy wasting S-albumin [39], S-creatinine [39], prealbumin [50]
 Sympathetic activation Norepinephrine [51]
 Coagulation/fibrinolysis disorders Fibrinogen [41]
 Insulin resistance HOMA [54]
 Genetics/epigenetics SNPs [188], telomere attrition [190], DNA-methylation [198]
 Vascular calcification PO4 [147], Ca [148], PTH [148], fetuin-A [156[, OPG [162], OPN [163]
 Classical uremic toxins S-creatinine [39], P-cresol [76]
 New uremic toxins Proteomics [183]
 Volume NT-pro-BNP [48], troponin-T [49]
 Subclinical hypothyroidism fT3 [172], T3 [174]
 Adipokines Leptin [58], visfatin [59], adiponectin [66]
 Anemia Hemoglobin [55]

HbA1c, glycated hemoglobin; Lp(a), lipoprotein(a); IL, interleukin; WBC, white blood cell count; MPO, myeloperoxidase; CRP, C-reactive protein; PTX3, pentraxin-3; ADMA, asymmetric dimethylarginine; oxLDL, oxidized LDL; AOPP, advanced oxidation protein products; tHcys, homocystine; U-alb, urinary albumin excretion; VCAM, vascular cell adhesion molecule; HOMA, homeostasis model assessment method; SNP, single nucleotide polymorphism; PTH, parathyroid hormone; OPG, osteoprotegerin; OPN, osteopontin; NT-pro-BNP, N-terminal pro-brain natriuretic peptide; T3, triiodothyronine.